The information in this section is intended for visitors outside the United States.
Cambridge, United Kingdom
Phone: 44 (0)1223 897300
Fax: 44 (0)1223 897291
280 High Holborn
Phone: 44 (0)0203 681 4500
Out of Hours: 44 (0)0203 681 4570
Fax: 44 (0)0203 681 469
Phone: +44 (0)8000 113 700
Phone: 44 (0) 203 681 4681
Fax: 44 (0)1223 897291
(all orders preferably to be faxed)
Alcura (UK) Ltd
Fax: 44 (0) 1420 89594
Phone: 44 (0)1223 897500
Fax: 44 (0)1223 897290
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases worldwide.
In addition to Gilead's international headquarters in the United Kingdom, there is also a sales and marketing office located in Cambridge, established in 1990. Gilead's Cambridge office is responsible for sales, marketing and clinical development in the United Kingdom and Ireland.
Relationships with Charitable Organizations
Relationships with Healthcare Professionals and Joint Working Projects
This page is intended for visitors outside of the United States.
Gilead Sciences makes payments to Healthcare Professionals and other relevant decision makers for consultancy and advisory services and provides sponsorship for educational activities that will ultimately benefit the care of patients.
The company has a policy of transparency as an important means of building and maintaining confidence. With effect from 2012, and in accordance with the ABPI Code of Practice, disclosure is therefore made of the total amount of fees paid to consultants for certain services and the total amounts paid to sponsor attendance at meetings organised by third parties.
For the purposes of this disclosure ‘Healthcare Professionals’ includes all members of the UK medical, dental, pharmacy and nursing professions and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine in the UK. The term ‘other relevant decision makers’ particularly includes those with an NHS role who could influence in any way the administration, consumption, prescription, purchase, recommendation, sale, supply or use of any medicine but who are not healthcare professionals.